Biopharma company Poxel closes private placement
Poxel, a French biopharmaceutical company focused on the treatments for metabolic disorders, has raised 17.7 million euros in a private placement.
Poxel, a French biopharmaceutical company focused on the treatments for metabolic disorders, has raised 17.7 million euros in a private placement.
Copyright PEI Media
Not for publication, email or dissemination